The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Mechanisms of hypoxia signalling: new implications for nephrology
Abstract
Studies of the regulation of erythropoietin (EPO) production by the liver and kidneys, one of the classical physiological responses to hypoxia, led to the discovery of human oxygen-sensing mechanisms, which are now being targeted therapeutically. The oxygen-sensitive signal is generated by 2-oxoglutarate-dependent dioxygenases that deploy molecular oxygen as a co-substrate to catalyse the post-translational hydroxylation of specific prolyl and asparaginyl residues in hypoxia-inducible factor (HIF), a key transcription factor that regulates transcriptional responses to hypoxia. Hydroxylation of HIF at different sites promotes both its degradation and inactivation. Under hypoxic conditions, these processes are suppressed, enabling HIF to escape destruction and form active transcriptional complexes at thousands of loci across the human genome. Accordingly, HIF prolyl hydroxylase inhibitors stabilize HIF and stimulate expression of HIF target genes, including the EPO gene. These molecules activate endogenous EPO gene expression in diseased kidneys and are being developed, or are already in clinical use, for the treatment of renal anaemia. In this Review, we summarize information on the molecular circuitry of hypoxia signalling pathways underlying these new treatments and highlight some of the outstanding questions relevant to their clinical use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIFs are significantly upregulated in many cancer types, and the application of HIF inhibitors as anticancer therapies has captured great interest.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [150]
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Self-citation
Research works printed but not linked: 2
- Viault, F. Sur l'augmentation considerable du nombre des globules rouges dans le sang chez les habitants des hauts plateaux de l'Amerique du Sud. Comptes Rendus Academie Sciences Paris 111, 917–918 (1890).
- Cockman, M. E. et al. Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates. e-Life (in the press).
Cited by
Sorted by citations
Items 101–200 of 313
Hypoxia hits APOL1 in the kidney
Grampp, S., Krüger, R., Lauer, V., Uebel, S., Knaup, K. X., Naas, J., Höffken, V., Weide, T., Schiffer, M., Naas, S., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.03.035 · Cited by 21
Self-citationHao, H., Hou, Y., Li, A., Niu, L., Li, S., He, B., Zhang, X., Song, H., Cai, R., Zhou, Y., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14300 · Cited by 20
Pan, S., Chiang, W., & Chen, Y. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.06.006 · Cited by 24
Shan, C., Xia, Y., Wu, Z., & Zhao, J. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.09.002 · Cited by 21
Zhu, B., Liu, W., Yu, D., Lin, Y., Li, Q., Tong, M., Li, Y., Yang, R., Du, Y., Tang, X.-L., et al. (2020) · American Journal of Nephrology · doi:10.1159/000508770 · Cited by 20
Safi, W., Kraus, A., Grampp, S., Schödel, J., & Buchholz, B. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01964-1 · Cited by 20
“HIF is a heterodimer consisting of a constitutively expressed β-subunit (HIF-β) and one of two alternative, oxygen-dependent α-subunits (HIF-1α and HIF-2α) which in the absence of oxygen accumulate and activate genes involved in metabolism, angiogenesis, immune reactions, and cell proliferation [16, 17].”
BackgroundSelf-citationChalkias, A. F., & Xenos, M. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164885 · Cited by 20
“Perfusion is important because hypoxia does not equate to a specific oxygen concentration; for example, many tissues function physiologically at levels equivalent to an atmosphere of 5% oxygen, and some at levels as low as 1% oxygen [6,7].”
BackgroundHIF-1α: A potential therapeutic opportunity in renal fibrosis
Liu, D., Wang, L., Ha, W., Li, K., Shen, R., & Wang, D. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110808 · Cited by 26
Liu, T., Yan, T.-T., Jia, X., Liu, J., Ma, R., Wang, Y., Wang, X., Liang, Y., Xiao, Y., & Dong, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114847 · Cited by 17
Sheng, W., Le, S., Song, Y., Du, Y., Wu, J. P., Tang, C., Wang, H., Chen, X., Wang, S., Luo, J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.851447 · Cited by 19
“The exact mechanism still needs further investigation, however, we speculate that inflammatory response and the regulation of erythropoietin production by the kidney and resultant oxygen delivery may play a role (27).”
BackgroundThe Arg/N-degron pathway targets transcription factors and regulates specific genes
Vu, T. T. M., Mitchell, D. C., Gygi, S. P., & Varshavsky, A. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020124117 · Cited by 19
Zheng, Q., Zhang, P., Yang, H., Geng, Y., Tang, J., Kang, Y., Qi, A., & Li, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15310 · Cited by 19
“As shown in the current study, the key mechanism of HIF-PHIs involved inhibiting the prolyl-hydroxyl domain (PHD) to stabilize HIF-α subunits (containing HIF-1α, HIF-2α, and HIF-3α) and increase HIF transcriptional activity [44].”
BackgroundHeck‐Swain, K., & Koeppen, M. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10050215 · Cited by 19
“This complex binds to hypoxia-responsive elements (HREs) in the promoter regions of target genes [12,13], regulating their expression in response to changes in oxygen levels [14].”
BackgroundModeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease
Millet-Boureima, C., He, S., Le, T. B. U., & Gamberi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083918 · Cited by 19
Burmakin, M., Fasching, A., Kobayashi, H., Urrutia, A. A., Damdimopoulos, A. E., Palm, F., & Haase, V. H. (2021) · Acta Physiologica · doi:10.1111/apha.13668 · Cited by 19
Huang, S., Jiang, X. S., Chen, Q., Hu, Z., Wang, F., Zhao, Y., Xin, G.-Z., & Chen, J. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104673 · Cited by 16
Li, Z., Meng, D.-D., Liu, Y., Bi, F., Tian, K., Xu, J., Sun, J.-G., Gu, C., & Li, Y. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109759 · Cited by 17
Distinct metabolic pathways mediate regulatory T cell differentiation and function
Hashimoto, H., McCallion, O., Kempkes, R. W. M., Hester, J., & Issa, F. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.04.011 · Cited by 16
“Constitutive degradation of hypoxia-inducible factor 1α (HIF-1α) is rapidly inhibited during severe hypoxia which promotes several cellular responses including modulating metabolic pathways to adapt to hypoxic conditions (60).”
BackgroundHigh-Altitude Andean H194R HIF2A Allele Is a Hypomorphic Allele
Jorgensen, K. C., Song, D., Weinstein, J. B., Garcia, O. A., Pearson, L. N., Inclán, M., Rivera, M. C., Lèon‐Velarde, F., Kiyamu, M., Brutsaert, T. D., et al. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad162 · Cited by 18
“40(7):msad162 https://doi.org/10.1093/molbev/msad162 Advance Access publication July 18, 2023 1 (Kaelin and Ratcliffe 2008; Majmundar et al. 2010; Semenza 2014; Schödel and Ratcliffe 2019).”
BackgroundInfluentialHypoxia research, where to now?
Ortmann, B. M., Taylor, C. T., & Rocha, S. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.03.008 · Cited by 18
Schley, G., Grampp, S., & Goppelt‐Struebe, M. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03186-w · Cited by 16
Wang, Y., Li, G., Deng, M., Liu, X., Huang, W., Zhang, Y., Liu, M., & Chen, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107783 · Cited by 16
Ischemic tubular injury: Oxygen-sensitive signals and metabolic reprogramming
Saadat, Y. R., Khatibi, S. M. H., Sani, A., Vahed, S. Z., & Ardalan, M. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01232-x · Cited by 15
“HIF exerts renoprotective effects by repressing kidney inflammation, enhanced scavenging of ROS, angiogenesis, erythropoiesis, preservation of vascular integrity and health, impacting O2 utilization and ROS production by mitochondria, controlling kidney O2 consumption, and reprogramming of glucose, adenosine metabolis…”
BackgroundHypoxia-induced conversion of sensory Schwann cells into repair cells is regulated by HDAC8
Hertzog, N., Duman, M., Bochud, M., Brügger‐Verdon, V., Gerhards, M., Schön, F., Dorndecker, F., Meijer, D., Fledrich, R., Stassart, R. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55835-9 · Cited by 16
“…HIF1 α upregulation can promote c-Jun-N-terminal kinases (JNK) activation 21,24 and both HIF1 α and phosphorylated JNK translocate to the cell nucleus 23,25,26 , which leads to JNK-dependent c-Jun phosphorylation and to the activation of c-Jun transcription 20,21 and c-Jun stabilization 27 .”
Zeh, N., Schlossbauer, P., Raab, N., Klingler, F., Handrick, R., & Otte, K. (2021) · Metabolic Engineering Communications · doi:10.1016/j.mec.2021.e00181 · Cited by 15
“Varying quantity, orientation and origin of HREs were tested and up to 10 repeats of the VEGF-A, EPO or PGK1 HREs displayed best induction upon hypoxia in human cells (Greco et al., 2002; Shibata et al., 2000).”
BackgroundZhang, Y., Zhu, J.-H., Zhou, Y., Li, Z.-T., Liu, H., Ma, R., & Li, Z. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111531 · Cited by 15
Zhang, J., Su, Q., Loudon, W. G., Lee, K. L., Luo, J., Dethlefs, B. A., & Li, S. C. (2019) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk4040071 · Cited by 14
“Ratcliffe (HIF-mediated hypoxia signaling, [2]), and geneticist Gregg L.”
BackgroundKidneys control inter-organ homeostasis
Puelles, V. G., & Huber, T. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00549-0 · Cited by 14
Hypoxia-Inducible Factors and Burn-Associated Acute Kidney Injury—A New Paradigm?
Enescu, D. M., Parasca, S. V., Bădoiu, S. C., Miricescu, D., Totan, A., Stănescu-Spînu, I.-I., Greabu, M., & Jinga, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052470 · Cited by 17
“The hypoxic stabilization of HIF-α is followed by its translocation into the cell nucleus, where it forms a heterodimer with HIF-β, that binds to the HRE domain of HIF target genes [104].”
BackgroundInfluentialChalkias, A. F., Adamos, G., & Mentzelopoulos, S. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124118 · Cited by 15
Popp, C. M., Miller, W., Eide, C. R., Tolar, J., McGrath, J. A., & Ebens, C. L. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.008 · Cited by 14
Yu, W., Liang, Y., Gao, J., & Xiong, J. (2024) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-024-02775-y · Cited by 14
“The inflammatory response and renal regulation of erythropoietin production, and consequently oxygen delivery, may play crucial roles in this association [49].”
BackgroundGenetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics
Gomez‐Virgilio, L., Velázquez-Paniagua, M., Cuazozon-Ferrer, L., Silva‐Lucero, M., Gutierrez‐Malacara, A., Padilla-Mendoza, J. R., Borbolla‐Vázquez, J., Díaz-Hernández, J. A., Jiménez-Orozco, F. A., & Cárdenas‐Aguayo, M. D. C. (2024) · Diagnostics · doi:10.3390/diagnostics14171909 · Cited by 18
“, the regulation of mTORC1 involves the protein regulated in”
BackgroundRamírez-delaCruz, M., Bravo‐Sànchez, A., Sánchez-Infante, J., Abián, P., & Abián‐Vicén, J. (2024) · Biology · doi:10.3390/biology13100835 · Cited by 15
“Then, this oxygen binds to hemoglobin and is transported to all organs of the body through the circulatory system [1,2].”
BackgroundZhang, Z., Wang, D., Xu, R., Li, X., Wang, Z., & Zhang, Y. (2024) · Biomolecules · doi:10.3390/biom14121592 · Cited by 14
“Targeting and inhibiting HIF-1 α activity or intervening in its downstream signaling pathways can slow or even reverse the osteogenic differentiation of VSMCs, thereby reducing the onset and progression of calcification [22,178].”
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD
Parfrey, P. S. (2021) · New England Journal of Medicine · doi:10.1056/nejme2117100 · Cited by 14
HIF-2α Preserves Mitochondrial Activity and Glucose Sensing in Compensating β-Cells in Obesity
Moon, J.-S., Riopel, M., Seo, J. B., Herrero-Aguayo, V., Isaac, R., & Lee, Y. S. (2022) · Diabetes · doi:10.2337/db21-0736 · Cited by 13
Hu, L., Hu, J., Huang, Y., Zheng, S., Ji, Y., Li, X., Li, D., Lv, C., Li, S., & Hu, W. (2023) · Medicine · doi:10.1097/md.0000000000032533 · Cited by 18
“Similarly, iron chelators and cobalt chloride, which increase HIF-1 activity and inhibit PHD by removing Fe (II) from the catalytic core.[23,27] Redox active chemicals that have an impact on PHDs indirectly control the activity of hypoxia-inducible factor-1.”
BackgroundXu, Y., Yang, J., Lu, F. Y., Ye, C., & Wang, C. (2023) · Kidney & Blood Pressure Research · doi:10.1159/000529165 · Cited by 13
“In addition to innate low oxygen tension in the kidney, pathological conditions across the progression of CKD, such as in fl ammation, anemia, and increased proteinuria, also lead to severe hypoxia in the kidney [6].”
BackgroundEffects of hypoxia environment on osteonecrosis of the femoral head in Sprague-Dawley rats
Yin, B., Chen, H., Zhang, W., Li, T.-Z., Gao, Q., & Liu, J. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01114-0 · Cited by 13
Enarodustat Treatment for Renal Anemia in Patients With Non-dialysis Chronic Kidney Disease
Mima, A. (2023) · In Vivo · doi:10.21873/invivo.13148 · Cited by 13
Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury
Zhao, Y., Zeng, H., Liu, B., He, X., & Chen, J. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00032.2020 · Cited by 13
PARylation promotes acute kidney injury via RACK1 dimerization-mediated HIF-1α degradation
Li, X., Shen, X., Mao, X., Wang, Y., Dong, Y., Sun, S., Zhang, M., Wei, J., Wang, J., Li, C., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.019 · Cited by 12
“The ubiquitination and proteasome degradation of HIF-1 α after hydroxylation by prolyl hydroxylase is the main way of HIF-1 α degradation 35 .”
Kunke, M., Knöfler, H., Dahlke, E., Rodriguez, L. Z., Böttner, M., Larionov, A. A., Saudenova, M., Ohrenschall, G. M., Westermann, M., Porubský, Š., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06074-7 · Cited by 12
“The most important known cellular oxygen-sensing machinery is hypoxiainducible factors (HIF) α and β, creating a functional complex for the initiation of the transcription of hypoxia-related genes [12].”
BackgroundWang, L., Song, Y., Zhang, P., Chen, W., Xiao, F., Zhou, P., Yang, X., & Dai, H. (2024) · The FASEB Journal · doi:10.1096/fj.202400047r · Cited by 12
“Increased expression of endogenous HIF-1 α was observed in a series of AKI animal models and AKI renal biopsy tissues, 23 and hypoxia-induced HIF-1 α activation was observed to play an important role in renal protection.”
BackgroundCross-platform transcriptomic profiling of the response to recombinant human erythropoietin
Wang, G., Kitaoka, T., Crawford, A., Mao, Q., Hesketh, A. R., Guppy, F. M., Ash, G. I., Liu, J. J., Gerstein, M., & Pitsiladis, Y. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-00608-9 · Cited by 12
“0 and Illumina HumanHT-12 v4 Expression BeadChip, (3) emphasis on experimental and bioinformatics techniques to reducing technical variations and tackling artefacts, (4) use of a relatively large number of the same experimental samples across the platforms, and (5) adoption of a data triangulation approach to prioriti…”
MethodKokado, Y., Kawai, K., Nanjo, T., Kinoshita, S., & Kondo, K. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.06.013 · Cited by 12
Lee, J., Kim, E., Chong, K., Ryu, S., Kim, C., Choi, K., Kim, J.-H., & Choi, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04529-2 · Cited by 12
“Cobalt chloride is known to stabilize HIF-1α in a hypoxia-independent manner by inhibiting prolyl hydroxylase [44, 45].”
BackgroundHIF2α regulates the synthesis and release of epinephrine in the adrenal medulla
Watts, D., Bechmann, N., Meneses, A., Poutakidou, I. K., Kaden, D., Conrad, C., Krüger, A., Stein, J., El‐Armouche, A., Chavakis, T., et al. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02121-y · Cited by 15
Jin, Y. H., Peng, Y., Xu, J., Yuan, Y., Yang, N., Zhang, Z., Xu, L., Li, L., Xiong, Y., Sun, D., et al. (2024) · Oncogenesis · doi:10.1038/s41389-024-00508-3 · Cited by 12
“Hydroxylation elicits HIF1 α ubiquitination by pVHL and subsequent degradation in the proteasome [17, 18].”
InfluentialZhou, X.-Y., Wang, J., & Zhou, S.-F. (2024) · Aging · doi:10.18632/aging.205693 · Cited by 24
Targeting HIF-1α in sickle cell disease and cancer: unraveling therapeutic opportunities and risks
Ubaid, S., Kashif, M., Laiq, Y., Nayak, A., Kumar, V., & Singh, V. K. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2367640 · Cited by 13
“Despite significant knowledge regarding the activation of the HIF gene program [10,74], the comprehensive transcriptional response triggered by hypobaric hypoxia due to high-altitude exposure in humans remains unexplored [75].”
BackgroundZhang, X., Ye, C., Lü, F., Yang, J., Xu, Y., & Wang, C. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2428337 · Cited by 11
Hu, J., Yang, B., Tao, Z., Chen, J., Zhang, X., Wang, S., Xing, G., Ngeng, N. A., Malik, A., Appiah‐Kubi, K., et al. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111327 · Cited by 12
Anemia in cardiorenal disease: From pathogenesis to treatment
Heng, J., Li, Z.-T., Yao, D., Li, X., Cui, M., & Li, Z.-L. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106506 · Cited by 11
The Endothelial Landscape and Its Role in Von Hippel–Lindau Disease
de Rojas-P, I., Albiñana, V., Taranets, L., Recio-Poveda, L., Cuesta, Á. M., Popov, N., Kronenberger, T., & Botella, L. M. (2021) · Cells · doi:10.3390/cells10092313 · Cited by 11
“HIF’s binding to promoters and enhancers of target genes regulates the hypoxic survival response [11].”
BackgroundDisturbance of Hypoxia Response and Its Implications in Kidney Diseases
Li, Z., Wang, B., Wen, Y., Wu, Q., Lv, L., & Liu, B. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0271 · Cited by 11
The interplay between H19 and HIF-1α in mitochondrial dysfunction in myocardial infarction
Xie, L., He, J., Mao, J., Zhang, Q., Bo, H., & Li, L. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110919 · Cited by 12
Yan, Y. Y., Zhang, X., Yao, Y.-T., & The Evidence in Cardiovascular Anesthesia (EICA) Group (2023) · Medicine · doi:10.1097/md.0000000000034668 · Cited by 10
“[20] In addition, diabetes mellitus was also reported as an independent risk factor for PPCs after cardiac surgery in some studies.”
BackgroundThe Mechanism of Acupuncture Regulating Autophagy: Progress and Prospect
He, J., He, M., Sun, M., Chen, H., Dou, Z., Nie, R., Zhou, J., Tang, Q., Che, C., Liu, J., et al. (2025) · Biomolecules · doi:10.3390/biom15020263 · Cited by 10
“Under hypoxic conditions, mitochondrial adenosine triphosphate (ATP) production is reduced in aerobic organisms, which cannot perform everyday life activities through cellular respiration [12].”
Hypoxia-inducible factor-prolyl hydroxylase inhibitors in treatment of anemia with chronic disease
Li, Z., Shen, L., Tu, Y., Lü, S., & Liu, B.-C. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003470 · Cited by 10
“[10,11] The HIF-PHI could stabilize HIF expression by inhibiting PHD and preventing N-terminal hydroxylation of HIF-α and subsequent HIF degradation.”
Zhao, H., Wang, S., Zhou, Y., Ertay, A., Williamson, P. T. F., Ewing, R. M., Tang, X., Wang, J., & Wang, Y. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.994036 · Cited by 10
“Studies have shown that regulating HIF levels provide novel therapeutic strategies for a broad variety of diseases, including anemia (De Bels et al., 2011; Semenza, 2012; Schodel and Ratcliffe, 2019).”
BackgroundNagashima, R., Ishikawa, H., Kuno, Y., Kohda, C., & Iyoda, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-29161-3 · Cited by 12
Hypoxia signaling in bone physiology and energy metabolism
Valle-Tenney, R., Melis, S., & Maes, C. (2023) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2023.100473 · Cited by 11
Chertow, G. M., Pérgola, P. E., Agarwal, R., Block, G. A., Farag, Y. M. K., Jardine, A. G., Koury, M. J., Luo, W. F., Khawaja, Z., Lewis, E. F., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.10.068 · Cited by 10
The Association between Serum Hemoglobin and Renal Prognosis of IgA Nephropathy
Oh, T. R., Song, S. H., Choi, H. S., Kim, C. S., Han, S. H., Kang, K. P., Kwon, Y., Kim, S. W., Kwon, S., & Bae, E. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020363 · Cited by 11
“CKD and anemia are known to be related through various mechanisms, and recent studies show that anemia might lead to hypoxic injury in end-organs, including the kidneys, through the hypoxia-inducible factor (HIF) signaling pathway [14,15].”
BackgroundRETSAT Mutation Selected for Hypoxia Adaptation Inhibits Tumor Growth
Jiang, X., He, Y., Shen, Q., Duan, L., Yuan, Y., Tang, L., Shi, Y., Liu, B., Zhai, H., Shi, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.744992 · Cited by 9
“These factors include hypoxia-inducible factors (HIFs), the von Hippel–Lindau (VHL) and prolyl hydroxylases (PHD1/2/3 or so-called EglN1/2/3, respectively) of the 2-oxoglutarate (or α-ketoglutarate) dioxygenase super-family (Schödel and Ratcliffe, 2019), which provide valuable therapeutic targets for various types of…”
BackgroundYan, H., Zhao, L., He, K., Liu, H., Zhang, C., Liu, Q., Song, K., Yang, H., Xu, T., & Yang, S. Y. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c00093 · Cited by 9
Zhang, W., Li, Y., & Wang, J. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14924 · Cited by 8
Effect of hypoxia on the mucus system and intragastric microecology in the gastrointestinal tract
Chen, L., Zhou, S., Yang, J. X., & Liu, X. Q. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107615 · Cited by 8
Acidosis attenuates the hypoxic stabilization of HIF-1α by activating lysosomal degradation
White, B., Wang, Z., Dean, M., Michl, J., Nieora, N., Flannery, S. E., Vendrell, I., Fischer, R., Hulı́ková, A., & Swietach, P. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202409103 · Cited by 8
Phosphate sensing in health and disease
Zechner, C., & Rhee, E. P. (2024) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000984 · Cited by 8
Putra, K. P., Pratama, R. P., & Nugroho, K. P. A. (2020) · JOSSAE (Journal of Sport Science and Education) · doi:10.26740/jossae.v5n1.p25-32 · Cited by 8
Yamazaki, S., Hirano, I., Kato, K., Yamamoto, M. P., & Suzuki, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119075 · Cited by 8
Giannopoulou, A. F., Velentzas, A. D., Anagnostopoulos, A. K., Agalou, A., Papandreou, N. C., Katarachia, S. A., Koumoundourou, D. G., Konstantakou, E. G., Pantazopoulou, V. I., Delis, A. D., et al. (2021) · Cancers · doi:10.3390/cancers13092024 · Cited by 8
Batie, M., Kenneth, N. S., & Rocha, S. (2022) · Biochemical Journal · doi:10.1042/bcj20210554 · Cited by 8
Huang, Q., Liao, Z., Liu, X., Xia, Y., & Wang, J. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03316-z · Cited by 8
“The corresponding inhibitors (HIF-PHIs) are a new class of drugs that activate HIF transcription factors and have broad therapeutic potential in clinical medicine [10].”
BackgroundDamarlapally, N., Thimmappa, V., Irfan, H., Sikandari, M. H., MADHU, K., Desai, A., Pavani, P., Zakir, S. J., Gupta, M., Khosa, M. M., et al. (2023) · Cureus · doi:10.7759/cureus.47430 · Cited by 11
Geis, L., & Kurtz, A. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae225 · Cited by 7
Huang, Q., You, M. J., Huang, W., Chen, J., Zeng, Q., Jiang, L., Du, X., Liu, X., Hong, M., & Wang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1050412 · Cited by 7
“HIF-PHIs are a new class of drugs that can activate HIF transcription factors and may have broad therapeutic potential in clinical practice (Schödel and Ratcliffe, 2019).”
BackgroundQi, Y., Hu, M., Wang, Z., & Shang, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115725 · Cited by 7
Yokouchi-Konishi, T., Liu, Y., & Feng, L. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad109 · Cited by 7
“Under non-hypoxic conditions, HIF1 α subunits have a very short half-life, only a few minutes [36], through ubiquitin–proteasome pathway-mediated protein degradation [37– 40].”
BackgroundIshiyama, Y., Yagisawa, T., Ichioka, M., Hagiwara, A., Shimizu, T., Omoto, K., Nozaki, T., Inui, M., Ino, J., Takeda, K., et al. (2024) · Transplantation Proceedings · doi:10.1016/j.transproceed.2024.05.029 · Cited by 7
Prolyl hydroxylase domain inhibitors prevent kidney crystal formation by suppressing inflammation
Kawase, K., Hamamoto, S., Unno, R., Taguchi, K., Okada, A., & Yasui, T. (2024) · Urolithiasis · doi:10.1007/s00240-024-01677-x · Cited by 7
Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?
Ottolenghi, S., Milano, G., Dei, M., Findley, T. O., Paroni, R. C., & Corno, A. F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770590 · Cited by 7
Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy
Xiao, A. Y., Kanaan, H. D., Lai, Z., Li, W., & Zhang, P. L. (2022) · International Urology and Nephrology · doi:10.1007/s11255-021-03078-0 · Cited by 7
“In contrast, hypoxia results in a retention of HIF-1α that subsequently activates many genes, such as erythropoietin and CD133, to deal with the hypoxic challenge [3, 4, 40].”
BackgroundVávra, J., Sergunin, A., Jeřábek, P., Shimizu, T., & Martínková, M. (2022) · Biological Chemistry · doi:10.1515/hsz-2022-0185 · Cited by 7
Huang, H., Huang, S., Li, C., Zhang, C., Wang, R., Wei, L., Wu, J., Mo, P., Li, Z., Li, S., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118607 · Cited by 6
Xu, M., Taylor, M. S., Hill, B. G., Li, X., Rouchka, E. C., McClain, C. J., & Song, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000572 · Cited by 9
“While HIF-1 α is ubiquitously expressed across normal tissues and cell types, [27,28] its role appears to be cell type – specific and context-specific.”
Naito, Y., Yasumura, S., Okuno, K., Asakura, M., Tsujino, T., Masuyama, T., & Ishihara, M. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003623 · Cited by 6
Ma, X., Pai, P. M., Zhu, W., Chen, X., & Cui, L. (2024) · CEN Case Reports · doi:10.1007/s13730-024-00865-3 · Cited by 6
Wei, L., He, P., Tan, Z., Zhao, L.-F., Lin, C., & Wei, Z. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18411 · Cited by 5
“8,9 Nevertheless, the intricate molecular mechanisms driving hypoxia-induced HCC progression remain predominantly unclear, warranting further studies for a comprehensive understanding.”
BackgroundConstruction and evaluation of a liver cancer risk prediction model based on machine learning
Wang, Y., Yang, W., Du, Q., Liu, Z., Lu, M., & You, C. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i9.3839 · Cited by 6
“Previous studies have demonstrated that patients with HCC exhibit upregulation of hypoxia inducible factor expression, which stimulates excessive production and secretion of erythropoietin, thereby leading to an elevated RBC count[20].”
Patel, S., Mohapatra, E., Suganthy, A. K., Shah, S., Abraham, J., Nanda, R., Behera, A. K., & Gupta, A. K. (2023) · Lung India · doi:10.4103/lungindia.lungindia_343_22 · Cited by 6
“[10] Among the various studied molecular mechanisms involved in the response to hypoxia at the cellular level, hypoxia-inducible factor-α (HIF-α) and erythropoietin (EPO) are used as key markers to detect hypoxia.[11] Therefore, measuring venous blood gas parameters along with measurement of oxygenation saturation (us…”
BackgroundEfficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia
Zhu, X., Zhang, C., Xu, T., Jiang, G.-N., & Li, Y. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i26.7682 · Cited by 5
Oxygen sensing, anaesthesia and critical care: a narrative review
Slingo, M., & Pandit, J. J. (2021) · Anaesthesia · doi:10.1111/anae.15582 · Cited by 5
Zhang, K., Yang, W., Ma, K., Qiu, J., Li, L., Xu, Y., Zhang, Z., Yu, C., Zhou, J., Gong, Y., et al. (2022) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108633 · Cited by 5
Bibliometric analysis of hypoxia inducible factor prolyl hydroxylase inhibitor in anemia
Zheng, L., Liu, M., Zhang, Y., Zhang, K., Gu, Y., & Liu, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1005225 · Cited by 4
“HIF⁃1α and HIF⁃2α all mediate the transcriptional response in hypoxia, but their distribution, transcriptional target and oxygen dependence are different (Schödel and Ratcliffe, 2019).”
BackgroundThe effect of physical exercise on vital lung capacity in Tapak Suci athletes
Sukadiono, S., Zahrah, S. F., Nasrullah, D., Supatmi, S., & Fitriyani, V. R. (2022) · Jurnal Keolahragaan · doi:10.21831/jk.v10i2.52392 · Cited by 8
“The ability of the respiratory muscles will improve as a result of muscular activities that are related to breathing (Schödel & Ratcliffe, 2019).”
BackgroundTargeting hypoxia-related metabolism molecules: How to improve tumour immune and clinical treatment?
Liang, B., Deng, L., & Zhou, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113917 · Cited by 6
Metadata
- Authors
- Schödel, J., & Ratcliffe, P. J.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- The Francis Crick Institute (GB)
- Corresponding author
- Ratcliffe, Peter J.
- Venue
- Nature Reviews Nephrology
- Published
- 2019-09-05
- Volume
- 15
- Issue
- 10
- Pages
- 641-659
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2971880737
- Cited by
- 309
- References
- 255
- Citations by year
- 2026: 22 · 2025: 36 · 2024: 48 · 2023: 64 · 2022: 53 · 2021: 54 · 2020: 31 · 2019: 1
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (FC001501)
- Cancer Research UK (FC001501)
- British Heart Foundation (RG/11/1/28684)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- hypoxia signaling, hypoxia-inducible factor, prolyl hydroxylase inhibitors, erythropoietin, anemia of chronic kidney disease, 2-oxoglutarate-dependent dioxygenase, oxygen sensing, kidney disease, HIF target genes
- MeSH terms
- Animals, Hypoxia, Humans, Kidney, Kidney Diseases, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review